Enstar Group Limited Reports Second Quarter Results

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Enstar Group Limited Reports Second Quarter Results

HAMILTON, Bermuda, Aug. 11, 2014 (GLOBE NEWSWIRE) -- Enstar Group Limited (Nasdaq: ESGR ) filed its quarterly report on Form 10-Q with the SEC earlier today, reporting its earnings and financial position for the three and six months ended June 30, 2014.

Enstar reported consolidated net earnings of $51.8 million (or $2.68 per fully diluted share) for the three months ended June 30, 2014 and $81.4 million (or $4.52 per fully diluted share) for the six months ended June 30, 2014, compared to $19.2 million (or $1.15 per fully diluted share) for the three months ended June 30, 2013 and $31.2 million (or $1.87 per fully diluted share) for the six months ended June 30, 2013.

Enstar's shareholders' equity at June 30, 2014 amounted to $2,199.8 million (or $113.94 per fully diluted share), as compared to $1,755.5 million (or $105.20 per fully diluted share) at December 31, 2013. The Form 10-Q, which is available on Enstar's website, www.enstargroup.com , contains a more detailed description of Enstar's business and financial results.

Enstar Group Limited and its operating subsidiaries acquire and manage diversified insurance businesses through a network of service companies in Bermuda, the United States, the United Kingdom, Continental Europe, Australia, and other international locations. Enstar is a market leader in completing run-off acquisitions, having acquired over 60 companies and portfolios since its formation in 2001. Enstar's active underwriting businesses include the Atrium group of companies, which manage and underwrite specialist insurance and reinsurance business for Lloyd's Syndicate 609, and the Torus group of companies, an A- rated global specialty insurance group with multiple global underwriting platforms, including Lloyd's Syndicate 1301. For further information about Enstar, see www.enstargroup.com .

This press release contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements include statements regarding the intent, belief or current expectations of Enstar and its management team. Investors are cautioned that any such forward-looking statements speak only as of the date they are made, are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those projected in the forward-looking statements as a result of various factors. Important risk factors regarding Enstar may be found under the heading "Risk Factors" in Enstar's Form 10-K for the year ended December 31, 2013 and Form 10-Q for the three and six months ended June 30, 2014, and are incorporated herein by reference. Furthermore, Enstar undertakes no obligation to update any written or oral forward-looking statements or publicly announce any updates or revisions to any of the forward-looking statements contained herein, to reflect any change in its expectations with regard thereto or any change in events, conditions, circumstances or assumptions underlying such statements, except as required by law.

Richard J. Harris (441) 292-3645

Scroll down for more posts ▼

Top 10 Most Recent News Articles

UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 40

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 41

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 22

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 35

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 53

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 27

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 32

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading

Top 5 Most Recently Viewed Articles

Transforming Cybersecurity: Passwork's New Breach Detection

Updated Category News Views 101

Innovative Solutions in Password Management Passwork, an industry leader in enterprise password management, has unveiled a groundbreaking solution promising to change the landscape of password breach detection forever. By employing advanced obfuscated deterministic Bloom filters, Passwork ensures organizations can check their passwords for breaches incredibly swiftly, all...

Continue Reading
Delta's UFC 500 Charger Earns German Certification for EVs

Updated Category News Views 121

Delta's UFC 500 Ultra-Fast EV Charger certified for quality Delta has made headlines with its remarkable 500kW Ultra-Fast EV Charger, known as the UFC 500 Series, achieving German Eichrecht certification. This milestone marks a significant advancement in the realm of electric vehicle (EV) charging, showcasing Delta's commitment to innovation and excellence in power...

Continue Reading
Savara Inc. Faces Class Action Lawsuit Over Regulatory Issues

Updated Category News Views 270

Savara Inc. Faces Class Action Lawsuit Over Regulatory Issues Recent developments in the biotech sector have captured the attention of investors as a class action lawsuit has been filed against Savara Inc. (NASDAQ: SVRA), a company dedicated to targeting rare respiratory diseases. This significant legal action, taken by Pomerantz LLP, has raised concerns among...

Continue Reading
ICG Enterprise Trust Completes Own Share Buyback Initiative

Updated Category News Views 164

ICG Enterprise Trust Announces Share Buyback ICG Enterprise Trust plc (the “Company”) has made significant strides in its investment strategy by officially announcing a recent buyback transaction. On 14 April 2025, the Company acquired 15,000 of its own shares, which will now be held as treasury shares, at an average purchase price of 1157 pence each. Details of the...

Continue Reading
Urgent Legal Notice for Novo Nordisk Shareholders - Act Now!

Updated Category News Views 152

Important Action Alert for Novo Nordisk Investors Bragar Eagel & Squire, P.C. is reaching out to all investors who experienced losses in Novo Nordisk (NVO). If you purchased or acquired Novo securities between May 7, 2025, and July 28, 2025, it's critical to be informed about your rights and potential legal options. Contact Information for Legal Assistance If your...

Continue Reading